⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHC News
Bausch Health Companies Inc
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
accessnewswire.com
BHC
BHC
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
accessnewswire.com
BHC
DRRX
BHC
DRRX
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
accessnewswire.com
BHC
BHC
Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics du Québec et de la Saskatchewan
accessnewswire.com
BHC
BHC
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
prnewswire.com
INCY
PRTH
BHC
ACRS
PFE
AMGN
BMY
VERU
LLY
MRK
ABBV
Bausch Health Announces US$50 Million Share Repurchase Program
prnewswire.com
BHC
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
prnewswire.com
BHC
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
prnewswire.com
BHC